Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1253

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 5
Chunk 1253
---
	* 
  
    Phil Geon Lee	 
     —  
     	* 
  
    Seng Chin Mah	 
     —  
     	* 
  
    Jin Whan Park(4)	 
     20,000  
     	* 
  
    All such executive officers and directors as a group (11 individuals)	 
     13,089,104  
     67.9%
  
    Greater than 5% Stockholders** 

    Bellevue Global Life Sciences Investors LLC(5)	 
     1,332,500  
     6.9%
  
    BCM Europe AG(6)	 
     8,612,634  
     44.7%
  
    Bellevue Capital Management LLC	 
     3,123,970  
     16.2%

*Less than one percent.

(1)Unless otherwise noted, the address of each beneficial owner is c/o OSR Holdings, Inc., 10900 NE 4th Street, Suite
2300, Bellevue, WA 98004.

(2)Interest consists of (i) 1,725,000 founder shares of the Company’s Common Stock, (ii) the transfer of 34,500 shares
of the Company’s common stock to Chardan Capital Markets, LLC (“Chardan”), (iii) 430,000 placement shares
held of record by Bellevue Global Life Sciences Investors LLC (“BGLSI”), (iv) the transfer of 120,000 shares
of the Company’s Common Stock by BGLSI to officers and directors of the Company at the time of its initial public offering, and
(v) the transfer of 310,000 private placement units  held by BGLSI and 370,000 founder shares held by BGLSI to BCM Europe AG
(“BCME”). BGLSI’s ownership an additional 12,000 shares underlying the private placement rights that
convert at the closing of the Business Combination and the shares of the Company’s Common Stock held by BCME and Bellevue Capital
Management LLC (“BCM”) upon the closing of the Business Combination. Mr. Hwang is the founder and managing partner
of BCM, the general partner of BGLSI, and has voting and dispositive power over the shares.

(3)Interest does not include shares of the Company’s Common Stock held by BGL